108 related articles for article (PubMed ID: 21354201)
1. L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
Ohmura Y; Jutkiewicz EM; Domino EF
Pharmacol Biochem Behav; 2011 Jun; 98(4):552-8. PubMed ID: 21354201
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptophan attenuates somatic signs of nicotine withdrawal.
Ohmura Y; Jutkiewicz EM; Yoshioka M; Domino EF
J Pharmacol Sci; 2011; 117(2):121-4. PubMed ID: 22001627
[TBL] [Abstract][Full Text] [Related]
4. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
Zaniewska M; McCreary AC; Wydra K; Filip M
Neuropharmacology; 2010 Jun; 58(7):1140-6. PubMed ID: 20153341
[TBL] [Abstract][Full Text] [Related]
5. Behavioral effects of nicotine withdrawal in adult male and female rats.
Hamilton KR; Berger SS; Perry ME; Grunberg NE
Pharmacol Biochem Behav; 2009 Mar; 92(1):51-9. PubMed ID: 19000707
[TBL] [Abstract][Full Text] [Related]
6. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Magallanes N; Blair MB; Alexander MR; McDavid L; Spurgeon JL; Ennifar S; Fattom A
Nicotine Tob Res; 2010 Apr; 12(4):438-44. PubMed ID: 20203107
[TBL] [Abstract][Full Text] [Related]
7. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
Mattioli L; Perfumi M
J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
[TBL] [Abstract][Full Text] [Related]
9. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
[TBL] [Abstract][Full Text] [Related]
10. Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
Jain R; Mukherjee K; Mohan D
Pharmacol Biochem Behav; 2008 Feb; 88(4):473-80. PubMed ID: 18031800
[TBL] [Abstract][Full Text] [Related]
11. Serotonin involvement in Rhodiola rosea attenuation of nicotine withdrawal signs in rats.
Mannucci C; Navarra M; Calzavara E; Caputi AP; Calapai G
Phytomedicine; 2012 Sep; 19(12):1117-24. PubMed ID: 22921986
[TBL] [Abstract][Full Text] [Related]
12. Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice.
Kotagale NR; Chopde CT; Umekar MJ; Taksande BG
Eur J Pharmacol; 2015 May; 754():190-8. PubMed ID: 25744879
[TBL] [Abstract][Full Text] [Related]
13. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.
Alam M; Mayerhofer A; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):117-24. PubMed ID: 15084427
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
[TBL] [Abstract][Full Text] [Related]
15. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
Varani AP; Moutinho LM; Calvo M; Balerio GN
Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
[TBL] [Abstract][Full Text] [Related]
16. Ovarian hormone withdrawal-induced "depression" in female rats.
Stoffel EC; Craft RM
Physiol Behav; 2004 Dec; 83(3):505-13. PubMed ID: 15581673
[TBL] [Abstract][Full Text] [Related]
17. Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs.
Mannucci C; Pieratti A; Firenzuoli F; Caputi AP; Calapai G
Phytomedicine; 2007 Oct; 14(10):645-51. PubMed ID: 17689233
[TBL] [Abstract][Full Text] [Related]
18. L-DOPA attenuates hyperactivity of Roborovskii hamsters.
Kabuki Y; Shigemi K; Hamasu K; Furuse M
Behav Pharmacol; 2009 May; 20(3):260-4. PubMed ID: 19404194
[TBL] [Abstract][Full Text] [Related]
19. Nicotine withdrawal in adolescent and adult rats.
O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
[TBL] [Abstract][Full Text] [Related]
20. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
